← Browse by Condition
Medical Condition
refractory malignant solid neoplasm
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Enrollment
63 pts
Location
United States, Austr...
Sponsor
Children's Oncology Group
NCT05053971 Phase 1, Phase 2
Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04119024 Phase 1
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi